Department of Dynamic, Clinical Psychology and Health Studies, Sapienza University of Rome, Via Dei Marsi 78, 00185, Rome, Italy.
Systems Biology Group Lab and The Experts Group on Inositols in Basic and Clinical Research (EGOI), Research Center in Neurobiology Daniel Bovet (CRiN), Rome, Italy.
Eat Weight Disord. 2024 Apr 26;29(1):31. doi: 10.1007/s40519-024-01659-3.
Several studies have investigated the association between anorexia nervosa and polymorphisms of genes regulating serotonin neurotransmission, with a focus on the rs6311 polymorphism of 5-HTR2A. However, inconsistent results of these studies and conflicting conclusions of existing meta-analyses complicate the understanding of a possible association. We have updated these results and evaluated the involvement of other serotonin receptor gene polymorphisms in anorexia nervosa.
Adhering to PRISMA guidelines, we have searched studies on anorexia nervosa and serotonin-regulating genes published from 1997 to 2022, selected those concerning receptor genes and meta-analyzed the results from twenty candidate gene studies on the 5-HTR2A rs6311 polymorphism and the 5-HTR2C rs6318 polymorphism.
Present analyses reveal an association for the 5-HTR2A rs6311 polymorphism, with G and A alleles, across eighteen studies (2049 patients, 2877 controls; A vs. G allele, Odds Ratio = 1.24; 95% Confidence Interval = 1.06-1.47; p = 0.009). However, after geographic subgrouping, an association emerged only in a Southern European area, involving five studies (722 patients, 773 controls; A vs. G allele, Odds Ratio = 1.82; 95% Confidence Interval = 1.41-2.37; p < 0.00001). No association was observed for the 5-HTR2C rs6318 polymorphism across three studies.
To date, the involvement in the pathophysiology of anorexia nervosa of the 5-HTR2A rs6311 polymorphism appears limited to a specific genetic and/or environmental context, while that of the 5-HTR2C rs6318 polymorphism seems excluded. Genome-wide association studies and epigenetic studies will likely offer deeper insights of genetic and environmental factors possibly contributing to the disorder.
III Evidence obtained from well-designed cohort or case-control analytic studies. Clinical trial registration PROSPERO registration number: CRD42021246122.
多项研究调查了厌食症与调节 5-羟色胺神经递质的基因多态性之间的关联,其中重点关注 5-HTR2A 的 rs6311 多态性。然而,这些研究的结果不一致,以及现有荟萃分析的结论相互矛盾,使得人们对可能的关联难以理解。我们更新了这些结果,并评估了其他 5-羟色胺受体基因多态性在厌食症中的作用。
根据 PRISMA 指南,我们搜索了 1997 年至 2022 年发表的关于厌食症和调节 5-羟色胺的基因的研究,选择了涉及受体基因的研究,并对 5-HTR2A 的 rs6311 多态性和 5-HTR2C 的 rs6318 多态性的二十项候选基因研究的结果进行了荟萃分析。
目前的分析表明,rs6311 多态性在 18 项研究(2049 名患者,2877 名对照;A 与 G 等位基因,优势比=1.24;95%置信区间=1.06-1.47;p=0.009)中存在关联。然而,在按地理位置分组后,仅在一个南欧地区的五项研究(722 名患者,773 名对照;A 与 G 等位基因,优势比=1.82;95%置信区间=1.41-2.37;p<0.00001)中存在关联。在三项研究中均未观察到 5-HTR2C 的 rs6318 多态性与该疾病的关联。
迄今为止,5-HTR2A 的 rs6311 多态性与厌食症的病理生理学的关系似乎仅限于特定的遗传和/或环境背景,而 5-HTR2C 的 rs6318 多态性则被排除在外。全基因组关联研究和表观遗传学研究可能会提供更多关于可能导致该疾病的遗传和环境因素的深入见解。
III 级证据,来源于设计良好的队列或病例对照分析研究。临床试验注册 PROSPERO 注册号:CRD42021246122。